FDA Adverse Event Injury Summary report: N

QUADROX-ID

MDR report key: 4188766 · Received October 17, 2014

Report

Report Number
8010762-2014-00814
Event Type
Injury
Date Received
October 17, 2014
Date of Event
September 18, 2014
Report Date
September 18, 2014
Manufacturer
MAQUET CARDIOPULMONARY AG
Product Code
DTZ
PMA / PMN Number
K101153
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

MAQUET CARDIOPULMONARY IS AWARE OF SIMILAR COMPLAINTS. THE DEVICES DISPLAYED A SIMILAR MALFUNCTION WHICH WERE TESTED AND EVALUATED UNDER AN OPTICAL MICROSCOPE. DELAMINATION OF SOME GAS FIBERS WAS OBSERVED WHICH ALLOWED FOR THE PRIMING SOLUTION OF BLOOD TO FLOW INSIDE THE GAP BETWEEN THE GAS FIBERS AND POLYURETHANE. GRAVITY THEN ALLOWED FOR PASSAGE TO THE GAS EXITING PATH ALONG THE HOUSING. THE MOST PROBABLE ROOT-CAUSE IS THE DELAMINATION OF THE HOLLOW GAS FIBERS FROM THE POLYURETHANE POTTING AREA. A REVIEW OF THE QUALITY CONTROL PROCESS CONFIRMS THAT 100% FUNCTIONAL INSPECTION FOR LEAKAGE IS PERFORMED DURING PRODUCTION. MAQUET CARDIOPULMONARY AG HAS INITIATED AN INTERNAL PROCESS (CAPA-(B)(4)) TO ADDRESS THE APPROPRIATE CORRECTIVE AND PREVENTIVE ACTION. A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED WHEN NEW INFO BECOMES AVAILABLE. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT 5 MINUTES AFTER INITIATING VA ECLS (VENO-ARTERIAL EXTRACORPOREAL LIFE SUPPORT), CONSISTENT BLOOD DROPS WERE NOTED COMING FROM THE VENT PORT AT BOTTOM OF OXYGENATOR. FLOW RATE THROUGH THE OXYGENATOR WAS 3LITERS/MIN. THE GAS EXCHANGE WAS ADEQUATE AND FUNCTIONING PROPERLY, HEAT EXCHANGE COMPONENT WERE FUNCTIONING ADEQUATELY AS WELL. THE RATE OF BLOOD LEAKAGE WAS NOT SLOWING DOWN. THE PERFUSIONIST DESCRIBED THE RATE AS "1-2 DROPS PER MINUTE". A DECISION WAS MADE TO EXCHANGE THE OXYGENATOR. THE OXYGENATOR WAS CHANGED OUT WITHOUT DIFFICULTY OR INCIDENT TO THE PATIENT. THIS PATIENT WAS ON ECLS SUPPORT FOR 5 DAYS PRIOR TO BEING TAKEN TO THE OPERATING ROOM FOR VALVE SURGERY. THE SURGERY WAS COMPLETED AND PATIENT PLACED BACK ONTO ECLS SUPPORT. THE INCIDENT DESCRIBED ABOVE OCCURRED IN THE OPERATING ROOM WHEN THE PATIENT WAS PLACED BACK ONTO ECLS SUPPORT. A FLUID LEAK WAS NOT OBSERVED DURING THE PRIMING OF THE NEW CIRCUIT. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
661289 QUADROX-ID OXYGENATOR, CARDIOPULMONARY BYPASS DTZ MAQUET CARDIOPULMONARY AG HMOD 70000-USA 70099027

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention